Wu, L., Bai, R., Zhang, Y., Chen, H., Wu, J., Chen, Z., Wang, H., Zhao, L.

Objective
Although immune checkpoint blockade (ICB) therapy represents a bright spot in antitumor immunotherapy, its clinical benefits in colorectal cancer (CRC) are limited. Therefore, a new target for mediating CRC immunosuppression is urgently need…